InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,547.51
(
0.70%
)
US TECH 100
19,764.00
(
0.62%
)
Dow Jones
39,305.98
(
-0.01%
)
Brent Oil
87.58
(
0.28%
)
Bitcoin
56,331.17
(
-1.14%
)
Post# of 252489
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: Titan V post# 216803

Friday, 01/26/2018 6:28:48 PM

Friday, January 26, 2018 6:28:48 PM

Post# of 252489
Celgene Says Juno, Impact Deals Won't Be Its Last
https://www.thestreet.com/story/14463223/1/celgene-not-done-making-deals.html

Following its agreements to buy Juno Therapeutics Inc. (JUNO) and Impact Biomedicines Inc., biopharmaceutical giant Celgene Corp. (CELG) said it continues to have an appetite for deals.

"We will continue to aggressively invest in research and development and to deploy capital to acquire or license the most promising science, technology and products," said Celgene CEO Mark J. Alles on an earnings call on Thursday, Jan. 25.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up